Literature DB >> 19089660

Secretory expression and purification of recombinant Escherichia coli heat-labile enterotoxin B subunit and its applications on intranasal vaccination of hantavirus.

Shouchun Cao1, Ying Zhang, Feng Liu, Qin Wang, Quanfu Zhang, Qinzhi Liu, Chuan Li, Mifang Liang, Dexin Li.   

Abstract

In order to further study the B subunit of the Escherichia coli heat-labile enterotoxin (LTB), we obtained the LTB gene from pathogenic E. coli, cloned it into the pET22b (+) prokaryotic expression vector, and expressed it as a fusion protein with His tag in E. coli BL21 (DE3). The recombinant LTB was expressed and purified by Ni2+ affinity chromatography. The biological activity of the purified recombinant LTB was assayed in a series of monosialotetrahexosylganglioside (GM1)-ELISA experiments. The recombinant LTB (rLTB) was efficiently expressed under the induction of 10 g/l lactose at 37 degrees C for 6 h and yielded up to 31% of the total bacterial protein. Fused with pelB signal peptide, rLTB was successfully localized to the periplasmic space. GM1-ELISA experiments showed that the rLTB obtained retains strong GM1 ganglioside-binding activity. The ELISA result of hantavirus nucleoprotein-specific secretory immunoglobulin A (sIgA) and IgG showed that intranasal administration of inactivated hantavirus with rLTB significantly increased the levels of hantavirus-specific sIgA (P<0.01) and IgG (P<0.01) in comparison with inactivated hatavirus alone. In summary, we have developed a method for the efficient secretory expression and purification of rLTB, and the inactivated hantavirus co-administered intranasally with rLTB could effectively induce both mucosal and humoral immune responses specific to hantavirus.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19089660     DOI: 10.1007/s12033-008-9101-4

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  20 in total

Review 1.  Review: optimizing inducer and culture conditions for expression of foreign proteins under the control of the lac promoter.

Authors:  R S Donovan; C W Robinson; B R Glick
Journal:  J Ind Microbiol       Date:  1996-03

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Effects of lactose as an inducer on expression of Helicobacter pylori rUreB and rHpaA, and Escherichia coli rLTKA63 and rLTB.

Authors:  Jie Yan; Shou-Feng Zhao; Ya-Fei Mao; Yi-Hui Luo
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

4.  Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli.

Authors:  T K Sixma; S E Pronk; K H Kalk; E S Wartna; B A van Zanten; B Witholt; W G Hol
Journal:  Nature       Date:  1991-05-30       Impact factor: 49.962

5.  Protective mucosal immunity to ocular herpes simplex virus type 1 infection in mice by using Escherichia coli heat-labile enterotoxin B subunit as an adjuvant.

Authors:  C M Richards; A T Aman; T R Hirst; T J Hill; N A Williams
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

6.  Cellular location of heat-labile enterotoxin in Escherichia coli.

Authors:  T R Hirst; L L Randall; S J Hardy
Journal:  J Bacteriol       Date:  1984-02       Impact factor: 3.490

7.  Heat-labile enterotoxin in Escherichia coli. Kinetics of association of subunits into periplasmic holotoxin.

Authors:  H Hofstra; B Witholt
Journal:  J Biol Chem       Date:  1985-12-15       Impact factor: 5.157

8.  Effects of frequent intranasal administration of adjuvant-combined influenza vaccine on the protection against virus infection.

Authors:  S Tamura; A Yajima; E Hatori; S Tamura; H Asanuma; Y Suzuki; C Aizawa; T Kurata
Journal:  Vaccine       Date:  1997-11       Impact factor: 3.641

9.  Nasal or intramuscular immunization of mice with influenza subunit antigen and the B subunit of Escherichia coli heat-labile toxin induces IgA- or IgG-mediated protective mucosal immunity.

Authors:  L Haan; W R Verweij; M Holtrop; R Brands; G J van Scharrenburg; A M Palache; E Agsteribbe; J Wilschut
Journal:  Vaccine       Date:  2001-04-06       Impact factor: 3.641

10.  Expression of synthetic neutralizing epitope of porcine epidemic diarrhea virus fused with synthetic B subunit of Escherichia coli heat-labile enterotoxin in tobacco plants.

Authors:  Tae-Jin Kang; So-Chon Han; Moon-Sik Yang; Yong-Suk Jang
Journal:  Protein Expr Purif       Date:  2005-08-19       Impact factor: 1.650

View more
  3 in total

1.  Cloning and Expression of Recombinant Human Endostatin in Periplasm of Escherichia coli Expression System.

Authors:  Abbas Mohajeri; Yones Pilehvar-Soltanahmadi; Mohammad Pourhassan-Moghaddam; Jalal Abdolalizadeh; Pouran Karimi; Nosratollah Zarghami
Journal:  Adv Pharm Bull       Date:  2016-06-30

2.  Th2-biased immune response and agglutinating antibodies generation by a chimeric protein comprising OmpC epitope (323-336) of Aeromonas hydrophila and LTB.

Authors:  Mahima Sharma; Pujarini Dash; Pramod K Sahoo; Aparna Dixit
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

Review 3.  Animal Models for the Study of Rodent-Borne Hemorrhagic Fever Viruses: Arenaviruses and Hantaviruses.

Authors:  Joseph W Golden; Christopher D Hammerbeck; Eric M Mucker; Rebecca L Brocato
Journal:  Biomed Res Int       Date:  2015-07-21       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.